nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—cardiovascular system—attention deficit hyperactivity disorder	0.0219	0.0562	CbGeAlD
Pentoxifylline—ADORA2A—forebrain—attention deficit hyperactivity disorder	0.0185	0.0473	CbGeAlD
Pentoxifylline—NT5E—midbrain—attention deficit hyperactivity disorder	0.0171	0.0439	CbGeAlD
Pentoxifylline—PDE5A—forebrain—attention deficit hyperactivity disorder	0.0168	0.0431	CbGeAlD
Pentoxifylline—ADORA1—forebrain—attention deficit hyperactivity disorder	0.0159	0.0409	CbGeAlD
Pentoxifylline—ADORA2A—cardiovascular system—attention deficit hyperactivity disorder	0.0156	0.04	CbGeAlD
Pentoxifylline—PDE5A—cardiovascular system—attention deficit hyperactivity disorder	0.0142	0.0365	CbGeAlD
Pentoxifylline—NT5E—nervous system—attention deficit hyperactivity disorder	0.0141	0.0361	CbGeAlD
Pentoxifylline—NT5E—central nervous system—attention deficit hyperactivity disorder	0.0135	0.0347	CbGeAlD
Pentoxifylline—ADORA1—cardiovascular system—attention deficit hyperactivity disorder	0.0135	0.0346	CbGeAlD
Pentoxifylline—ADORA2B—nervous system—attention deficit hyperactivity disorder	0.012	0.0309	CbGeAlD
Pentoxifylline—PDE4B—forebrain—attention deficit hyperactivity disorder	0.0118	0.0302	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—attention deficit hyperactivity disorder	0.0116	0.0297	CbGeAlD
Pentoxifylline—ADORA2B—cerebellum—attention deficit hyperactivity disorder	0.0113	0.0291	CbGeAlD
Pentoxifylline—NT5E—brain—attention deficit hyperactivity disorder	0.0108	0.0276	CbGeAlD
Pentoxifylline—ADORA1—midbrain—attention deficit hyperactivity disorder	0.0105	0.027	CbGeAlD
Pentoxifylline—PDE4A—cerebellum—attention deficit hyperactivity disorder	0.0101	0.0259	CbGeAlD
Pentoxifylline—ADORA2A—nervous system—attention deficit hyperactivity disorder	0.01	0.0257	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—attention deficit hyperactivity disorder	0.00965	0.0247	CbGeAlD
Pentoxifylline—ADORA2A—cerebellum—attention deficit hyperactivity disorder	0.00943	0.0242	CbGeAlD
Pentoxifylline—ADORA2B—brain—attention deficit hyperactivity disorder	0.00921	0.0236	CbGeAlD
Pentoxifylline—PDE5A—nervous system—attention deficit hyperactivity disorder	0.00913	0.0234	CbGeAlD
Pentoxifylline—PDE5A—central nervous system—attention deficit hyperactivity disorder	0.00879	0.0225	CbGeAlD
Pentoxifylline—ADORA1—nervous system—attention deficit hyperactivity disorder	0.00866	0.0222	CbGeAlD
Pentoxifylline—PDE5A—cerebellum—attention deficit hyperactivity disorder	0.00859	0.022	CbGeAlD
Pentoxifylline—ADORA1—central nervous system—attention deficit hyperactivity disorder	0.00833	0.0214	CbGeAlD
Pentoxifylline—PDE4A—brain—attention deficit hyperactivity disorder	0.00821	0.021	CbGeAlD
Pentoxifylline—ADORA1—cerebellum—attention deficit hyperactivity disorder	0.00815	0.0209	CbGeAlD
Pentoxifylline—PDE4B—midbrain—attention deficit hyperactivity disorder	0.00779	0.02	CbGeAlD
Pentoxifylline—ADORA2A—brain—attention deficit hyperactivity disorder	0.00766	0.0196	CbGeAlD
Pentoxifylline—PDE5A—brain—attention deficit hyperactivity disorder	0.00698	0.0179	CbGeAlD
Pentoxifylline—ADORA1—brain—attention deficit hyperactivity disorder	0.00662	0.017	CbGeAlD
Pentoxifylline—PDE4B—nervous system—attention deficit hyperactivity disorder	0.0064	0.0164	CbGeAlD
Pentoxifylline—PDE4B—central nervous system—attention deficit hyperactivity disorder	0.00616	0.0158	CbGeAlD
Pentoxifylline—PDE4B—cerebellum—attention deficit hyperactivity disorder	0.00603	0.0154	CbGeAlD
Pentoxifylline—PDE4B—brain—attention deficit hyperactivity disorder	0.00489	0.0125	CbGeAlD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00172	0.00281	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00166	0.00273	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00166	0.00272	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00165	0.00271	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00165	0.00271	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00163	0.00268	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00163	0.00267	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00161	0.00264	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00161	0.00264	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00157	0.00258	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00155	0.00254	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00154	0.00253	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00154	0.00253	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00154	0.00252	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0015	0.00246	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0015	0.00246	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00149	0.00244	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00147	0.00241	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00146	0.0024	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00145	0.00238	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00144	0.00237	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00144	0.00237	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00143	0.00234	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00143	0.00234	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00142	0.00234	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00141	0.0023	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0014	0.0023	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0014	0.0023	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0014	0.00229	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00138	0.00226	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00138	0.00226	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00136	0.00222	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00135	0.00222	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00135	0.00221	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00134	0.00219	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00132	0.00217	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00132	0.00217	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00131	0.00215	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00131	0.00214	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0013	0.00213	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0013	0.00212	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00128	0.0021	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00127	0.00208	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00127	0.00207	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00126	0.00207	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00126	0.00207	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00126	0.00206	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00125	0.00204	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00124	0.00204	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00124	0.00204	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00124	0.00203	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00123	0.00201	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00123	0.00201	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00122	0.00199	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0012	0.00197	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00119	0.00195	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00118	0.00193	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00116	0.0019	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00114	0.00188	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00114	0.00187	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.0011	0.00181	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00109	0.00178	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00107	0.00175	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00107	0.00175	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00106	0.00173	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00105	0.00173	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.00172	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00103	0.00169	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00101	0.00166	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00101	0.00165	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000983	0.00161	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000977	0.0016	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00097	0.00159	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00097	0.00159	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00096	0.00157	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000948	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000948	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000943	0.00155	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000938	0.00154	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000934	0.00153	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000919	0.00151	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000909	0.00149	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000898	0.00147	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000892	0.00146	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000884	0.00145	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000881	0.00144	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000868	0.00142	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000848	0.00139	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000848	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000844	0.00138	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000841	0.00138	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000841	0.00138	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000835	0.00137	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—COMT—attention deficit hyperactivity disorder	0.000835	0.00137	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000829	0.00136	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000827	0.00136	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000827	0.00136	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000826	0.00135	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000826	0.00135	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000825	0.00135	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000816	0.00134	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000815	0.00134	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000813	0.00133	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000811	0.00133	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000801	0.00131	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000795	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000794	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000789	0.00129	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000789	0.00129	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000785	0.00129	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00077	0.00126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000769	0.00126	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000767	0.00126	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000764	0.00125	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000764	0.00125	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000761	0.00125	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000751	0.00123	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000751	0.00123	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000751	0.00123	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000741	0.00122	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000741	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000738	0.00121	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000736	0.00121	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00073	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000721	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000718	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000716	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000715	0.00117	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000713	0.00117	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000709	0.00116	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000707	0.00116	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000703	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000703	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000702	0.00115	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000695	0.00114	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000695	0.00114	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000694	0.00114	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000693	0.00114	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000691	0.00113	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000691	0.00113	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00069	0.00113	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000686	0.00112	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000682	0.00112	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000681	0.00112	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000673	0.0011	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00067	0.0011	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000669	0.0011	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000663	0.00109	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000649	0.00106	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000647	0.00106	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000645	0.00106	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000642	0.00105	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000639	0.00105	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000638	0.00105	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000637	0.00104	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000631	0.00103	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00063	0.00103	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000627	0.00103	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000623	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000619	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000614	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000613	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000587	0.000963	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00058	0.000951	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000573	0.00094	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00057	0.000935	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000557	0.000913	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000554	0.000909	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000554	0.000908	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000554	0.000908	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000552	0.000905	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000543	0.00089	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000543	0.00089	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000536	0.000879	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000533	0.000873	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000532	0.000873	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000521	0.000853	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000518	0.000849	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000501	0.000822	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000501	0.000822	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000499	0.000819	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000493	0.000808	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000487	0.000799	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000487	0.000798	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000484	0.000793	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000484	0.000793	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000482	0.00079	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000466	0.000764	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000455	0.000746	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000453	0.000743	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000453	0.000743	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000451	0.00074	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00045	0.000738	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000448	0.000734	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000447	0.000732	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000444	0.000727	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000443	0.000727	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000439	0.00072	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000438	0.000718	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000426	0.000699	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000423	0.000694	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000421	0.00069	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000411	0.000674	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00041	0.000672	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000408	0.000669	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000406	0.000666	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000403	0.00066	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000398	0.000652	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000396	0.000649	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000391	0.000642	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000384	0.000629	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000379	0.000621	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000377	0.000618	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000376	0.000617	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000373	0.000611	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000372	0.000611	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00037	0.000607	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000368	0.000603	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—EP300—attention deficit hyperactivity disorder	0.000358	0.000587	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00035	0.000573	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000347	0.000569	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000343	0.000562	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000329	0.000539	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000318	0.000521	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000306	0.000501	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000296	0.000486	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000291	0.000477	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000288	0.000471	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000286	0.000469	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000268	0.000439	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000259	0.000425	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000243	0.000398	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00024	0.000394	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000188	0.000308	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000184	0.000302	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000151	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000137	0.000225	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000129	0.000211	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000127	0.000209	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000127	0.000208	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000127	0.000208	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000125	0.000205	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000116	0.00019	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000102	0.000166	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.94e-05	0.000163	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.66e-05	0.000158	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	7.69e-05	0.000126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	7.64e-05	0.000125	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.41e-05	0.000121	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.3e-05	5.41e-05	CbGpPWpGaD
